Doença hepática gordurosa não alcoólica
Revisado por Dr Colin Tidy, MRCGPÚltima atualização por Dr Doug McKechnie, MRCGPÚltima atualização 22 Fev 2023
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Versão em Áudio
- Adicionar às fontes preferidas no Google
Nesta série:Doença hepática e álcoolÁlcool e consumo responsável - limites seguros de álcoolAlcoolismo e consumo problemático de álcoolAbstinência de álcool e desintoxicação alcoólica
A doença hepática gordurosa não alcoólica (DHGNA) descreve uma variedade de condições causadas pelo acúmulo de gordura nas células do fígado.
Em resumo
Non-alcoholic fatty liver disease (NAFLD) is fat build-up in the liver, not due to alcohol.
It is common in the UK, especially in people who are obese or overweight.
Most people with NAFLD do not develop serious liver problems.
Gradual weight loss and regular exercise are the main treatments.
These can also reduce the risk of heart attacks and strokes.
NAFLD is often found when blood tests are done for other reasons.
It is very common and in many cases is linked to being obese or overweight. Most people with NAFLD do not develop serious liver problems. In some people, the build-up of fat in the liver can lead to serious liver disease. However, all people with NAFLD have an increased risk of developing cardiovascular problems such as heart attacks and stroke.
If you are obese or overweight, the main treatment advised for NAFLD is usually gradual weight loss and regular exercise. This not only helps with NAFLD, but will help reduce your risk of developing cardiovascular problems. Other treatment methods are discussed below.
What is non-alcoholic fatty liver disease?
NAFLD describes a range of conditions caused by a build-up of fat within liver cells. NAFLD occurs in people who do not drink excessive amounts of alcohol, and so alcohol is not the cause. People who drink excessive amounts of alcohol can develop a condition called 'alcoholic fatty liver disease'.
Most people with NAFLD only have the early stage - 'simple fatty liver'. Only a minority will progress to develop inflammation of the liver (called non-alcoholic steatohepatitis, or NASH). And, only a minority of people with NASH will progress to develop cirrhosis. It is not clear why some people with simple fatty liver progress to the more severe forms of NAFLD, and most do not.
It is helpful to divide NAFLD into four stages:
Simple fatty liver (hepatic steatosis)
Normally, very little fat is stored in liver cells. Simple fatty liver means that excess fat builds up (accumulates) in liver cells. For most people, simple fatty liver does not cause any harm or problems to the liver, although it might be picked up on blood tests done for another reason - this is usually how it's detected. However, in some people it can progress to more severe forms of NAFLD.
Non-alcoholic steatohepatitis (NASH)
n this condition the excess fat in the liver cells is associated with, or may cause, inflammation of the liver. ('Steato' means fat, and 'hepatitis' means inflammation of the liver). This is much less common than simple fatty liver.
Fibrosis
Any form of persistent hepatitis, including steatohepatitis, may eventually cause scar tissue (fibrosis) to form within the liver. When fibrosis first develops often there are many liver cells that continue to function quite well.
Cirrose
This is a serious condition where normal liver tissue is replaced by a lot of fibrosis (scarring). The structure and function of the liver are badly disrupted. It is, in effect, like a severe form of liver fibrosis. Many liver conditions can lead to cirrhosis, including NAFLD. Severe cirrhosis can lead to liver failure. Consulte o folheto separado chamado Cirrose para mais detalhes.
Other forms of fatty liver
A condition similar to NAFLD can affect people who do drink a lot of alcohol. Read more about alcohol and liver disease for more details. Another fatty liver condition called fatty liver of pregnancy is a rare but serious condition of pregnancy. In this condition a lot of fat builds up in the liver cells and causes damage quite quickly. The cause is not known. Symptoms include being sick (vomiting), tummy (abdominal) pain and jaundice. Jaundice is a condition caused by a build-up in the body of a chemical called bilirubin, where your skin and other body parts turn a yellow colour.
The rest of this section is only about NAFLD.
O que o fígado faz?
The liver is in the upper right part of the tummy (abdomen). Its functions include:
Storing fuel for the body. Much of the food we eat is broken down by the body into a type of sugar called glucose. This is what our bodies use for energy. Glucose can't be stored so it is turned into a storage version called glycogen. This is kept in the liver and, when we need energy, it releases it in the form of glucose. The liver also stores iron and vitamins.
Produzindo proteínas essenciais para a coagulação do sangue (fatores de coagulação).
Helping to remove or process alcohol, medicines and poisons from the body.
Making a type of fat called cholesterol. This is needed in the body, although too much of it causes harm.
Making a juice called bile, which digests fat. This passes from the liver to the gut down the bile duct. Bile breaks down the fats in food so that they can be absorbed from the bowel.
How common is non-alcoholic fatty liver disease?
NAFLD is the most common persistent (chronic) liver disorder in western countries such as the UK. It is thought to occur in about 1 in 5 adults in the UK and in up to 4 in 5 adults who are obese. (However, most of these people have 'simple fatty liver' and not the more serious types of NAFLD.)
People with NAFLD have a higher chance of developing type 2 diabetes and cardiovascular disease (this includes heart attacks and strokes). Also, as NAFLD is common, some people with NAFLD also have another liver disorder. NAFLD can make the other liver disorder worse.
The risk factors for developing NAFLD include:
Obesidade
Most people with NAFLD are obese or overweight. However, the relationship between body fat and NAFLD, and factors that determine which people with obesity will develop NAFLD, are not clear. So, for example, some people who are only mildly overweight develop NAFLD. On the other hand, some people who are very obese do not develop NAFLD.
Diabetes
People with type 2 diabetes have an increased risk of developing NAFLD. However, there is no increased risk for those with type 1 diabetes.
Idade
NAFLD is more common in people aged over 50 years. It is also more common in men.
Pressão alta (hipertensão)
People with hypertension are at a greater risk of developing NAFLD.
High level of blood fats (hyperlipidaemia)
If you have a high level of cholesterol and/or triglycerides in your blood then you have a higher risk of developing NAFLD.
Very rapid weight loss
For example, NAFLD develops in some people following surgery to reduce obesity. This may be due to rapid changes of fats and fatty acids in the blood that occur when weight loss is rapid.
Medicamentos
Medication, like metotrexato e tamoxifeno for example, can, rarely, cause NAFLD.
What are the symptoms of non-alcoholic fatty liver disease?
Most people with simple fatty liver or non-alcoholic steatohepatitis (NASH) have no symptoms. However, some people with simple fatty liver or NASH have a nagging persistent pain in the upper right part of the tummy (abdomen), over an enlarged liver. You may feel generally tired if you have NASH. As most people do not have symptoms, the diagnosis is often first suspected when an abnormal blood test result occurs.
A small proportion of people with NAFLD develop cirrhosis. Cirrhosis is a condition where normal liver tissue is replaced by a lot of scar tissue (fibrosis).
How is non-alcoholic fatty liver disease diagnosed?
There is no simple test that can confirm NAFLD. Blood tests called liver function tests (LFTs) measure the blood levels of certain chemicals (enzymes) made by the liver cells. An abnormal pattern of LFTs may suggest that you have NAFLD. However, many other liver conditions can cause abnormal LFTs.
Therefore, if you have abnormal LFTs, a doctor will usually then do various other blood tests to rule out other causes of liver problems. For example, blood tests to detect various infections (such as hepatite B e hepatite C) and other causes of liver damage.
LFTs are tests that are done for various reasons. Therefore, NAFLD is often first suspected when an abnormal result occurs when the tests are done for an unrelated reason.
A scan of the liver can be helpful. For example, an ultrasound scan, CT scan or MRI scan. The scan can show an enlarged liver compatible with the diagnosis of NAFLD, and can also show signs of other causes of liver problems. However, a scan cannot definitely diagnose NAFLD.
The diagnosis of NAFLD is usually based on the abnormal LFTs and scan being compatible with NAFLD, and ruling out other causes of liver problems. If there is doubt about the diagnosis, a specialist may arrange a small sample (biopsy) to be taken from your liver.
This can be looked at under the microscope and can show the extent of any fatty accumulation, inflammation, scarring, etc, in the liver. Consulte o folheto separado chamado Biópsia do Fígado para mais detalhes.
However, a liver biopsy is not routinely done when simple fatty liver or non-alcoholic steatohepatitis (NASH) is the likely diagnosis, as there is some risk involved when doing a liver biopsy. A liver biopsy is mainly done if the diagnosis is in doubt, or if there is concern that cirrhosis has developed.
Blood tests can look for signs of fibrosis (scarring) of the liver. GPs might use a calculator called FIB-4 to estimate how likely there is to be liver scarring. Another blood test, called the Enhanced Liver Fibrosis (ELF®) test, can be useful as well for this.
A test called a FibroScan® is increasingly being used for people with NAFLD. A FibroScan® checks the stiffness of the liver. It can be used to detect liver scarring, including signs of cirrhosis. In some cases, it can avoid the need for a liver biopsy. Currently, in the UK, it's mainly used by hospital specialists for people who are at high risk of having liver scarring, although it might be used more widely in future.
What is the treatment for non-alcoholic fatty liver disease?
Redução de peso
Most cases of NAFLD are linked to being obese or overweight. There is good evidence that a programme of gradual weight loss and regular exercise can reduce the amount of fat in your liver. So, if you have simple fatty liver or mild NASH, this may prevent or delay the progression of NAFLD. It may reduce your chance of developing cirrhosis - a condition where normal liver tissue is replaced by a lot of scar tissue (fibrosis).
Aerobic exercise and diet changes are the most effective way to manage NAFLD. Try to aim for 150-200 minutes of moderate-intensity exercise a week - split over 3-5 sessions. It's a good idea to drink water instead of sugary drinks. Switching to a dieta mediterrânea can reduce liver fat, even if you don't lose weight. See the perda de peso leaflet for more ideas.
In some people who are very obese, obesity surgery may be considered, as studies have shown that this may help to improve NASH.
Treatment of linked conditions and risk factors
As mentioned, having NAFLD increases your risk of developing cardiovascular disease. In fact, people with NAFLD are actually more likely to become ill and die from cardiovascular diseases such as heart attacks than from a liver problem. Therefore, your doctor is likely to stress the importance of reducing any 'lifestyle' risk factors that increase the risk of developing cardiovascular disease. For example, not smoking, keeping your weight in check, taking regular exercise and eating a healthy balanced diet. See the separate leaflet called Cardiovascular Disease (Atheroma) for more details. Also, to treat high blood pressure (hypertension) and a high cholesterol level (hyperlipidaemia), if appropriate.
If you have diabetes, good control of your blood sugar (glucose) level is thought to help reduce the risk of NAFLD becoming worse.
It's important not to drink alcohol above the national recommended limits - which is a maximum of 14 units a week, spread across three days or more, ideally with several drink-free days each week. No amount of alcohol is completely risk-free, but it's thought that drinking below these levels is low risk.
Medication that affects the liver itself
Various medicines have been suggested as possible treatments for NAFLD. At the moment, no drugs are specifically licensed to treat NAFLD, and we don't have any medicines that are suitable to treat NAFLD in the early stages (such as simple fatty liver).
For people with a lot of liver scarring due to NAFLD, two medicines seem to help to reduce scarring. These are vitamin E, and pioglitazone. These might be offered by liver specialists.
Qual é a perspectiva?
The outlook (prognosis) for most people with NAFLD, is that the condition does not progress beyond simple fatty liver or non-alcoholic steatohepatitis (NASH). Cirrhosis - a condition where normal liver tissue is replaced by a lot of scar tissue (fibrosis) - and serious liver problems do not develop in most cases. The condition may reverse and even go away by weight loss (if you are overweight or obese) or with good control of diabetes (if diabetes is the cause).
However, fatty liver does progress to NASH in some people and NASH progresses to cirrhosis in some people. It is not clear why some people with NASH (and not others) progress to cirrhosis. Cirrhosis is very serious; it can lead to liver failure and may be fatal. A liver transplant may be required in very severe cirrhosis.
It is estimated that, on average:
About 2 in 100 people with simple fatty liver progress to cirrhosis over 15-20 years.
About 12 in 100 people with NASH progress to cirrhosis over about eight years.
So, most people with NAFLD do not develop serious liver disease. However, because NAFLD has become very common in recent years (probably because obesity has become much more common), NAFLD has become a common cause of cirrhosis.
However, also remember that cardiovascular disease is the most common cause of illness and death in people with NAFLD. Perhaps the most important 'take home message' if you are diagnosed with NAFLD is not to focus too much on your liver. Rather, concentrate on reducing any risk factors for developing cardiovascular problems. This is mainly lifestyle changes - in particular, diet, weight loss and exercise for most people and parando de fumar if you smoke.
Escolhas do paciente para Fígado e vesícula biliar

Saúde digestiva
Insuficiência hepática
A insuficiência hepática ocorre quando grandes partes do fígado ficam danificadas e não podem ser reparadas. O fígado não consegue funcionar corretamente. A insuficiência hepática pode fazer você se sentir muito mal. A insuficiência hepática aguda é uma condição com risco de vida e requer cuidados médicos de emergência. A insuficiência hepática geralmente se desenvolve lentamente ao longo de muitos anos. Isso é chamado de doença hepática crônica. Veja o folheto separado chamado Cirrose para mais informações. A insuficiência hepática também pode se desenvolver rapidamente em apenas alguns dias (insuficiência hepática aguda). Existem muitas causas de insuficiência hepática aguda. Estas incluem envenenamento por paracetamol, infecções (por exemplo, hepatite B ou hepatite C), fígado gorduroso agudo da gravidez e uma série de condições genéticas raras. Para algumas pessoas com insuficiência hepática, a causa é desconhecida.
por Dra. Hayley Willacy, FRCGP

Saúde digestiva
Síndrome de Gilbert
A síndrome de Gilbert é causada por um defeito hereditário no processamento da bilirrubina no fígado. A bilirrubina é produzida a partir da decomposição das células vermelhas do sangue. Quando não pode ser eliminada adequadamente no fígado, seus níveis aumentam no sangue. Isso pode causar icterícia leve de tempos em tempos e também pode ser visto como níveis ligeiramente elevados de bilirrubina em um exame de sangue. A síndrome de Gilbert não requer nenhum tratamento.
por Dr. Colin Tidy, MRCGP
Perguntas frequentes
Can fatty liver disease affect other organs in my body?
While the primary impact of non-alcoholic fatty liver disease (NAFLD) is on the liver, people with the condition have an increased risk of developing cardiovascular problems like heart attacks and strokes. It can also increase the chance of developing type 2 diabetes. Additionally, if a person with NAFLD already has another liver disorder, NAFLD can potentially worsen that existing condition.
Are there any specific lifestyle changes that are particularly effective for managing NAFLD?
Yes, lifestyle changes are very effective. Gradual weight loss and regular exercise are key. Aim for 150-200 minutes of moderate-intensity exercise per week, spread across 3-5 sessions. Making dietary changes like drinking water instead of sugary drinks and switching to a Mediterranean diet can also help reduce liver fat, even if you don't lose weight.
Is it possible for non-alcoholic fatty liver disease to go away completely?
For most people, non-alcoholic fatty liver disease (NAFLD) does not progress to serious liver problems. The condition can sometimes reverse and even go away, particularly if the individual is overweight or obese and successfully loses weight, or if diabetes (if it's a contributing cause) is well controlled.
Why is it important to control existing health conditions if I have NAFLD?
Controlling existing health conditions is crucial because NAFLD increases your risk of cardiovascular disease, which is actually the most common cause of illness and death for people with NAFLD. Therefore, managing conditions like high blood pressure and high cholesterol, and maintaining good control of blood sugar if you have diabetes, are important steps to reduce your overall health risks.
How are medication and alcohol related to non-alcoholic fatty liver disease?
While non-alcoholic fatty liver disease (NAFLD) is not caused by excessive alcohol, it's still important to not drink above national recommended limits (a maximum of 14 units a week, spread over three days or more). Some medications, though rarely, can also cause NAFLD; examples include methotrexate and tamoxifen.
What is the medical outlook if I have simple fatty liver compared to non-alcoholic steatohepatitis (NASH)?
For most people with simple fatty liver or mild non-alcoholic steatohepatitis (NASH), the condition does not progress to cirrhosis or serious liver problems. While about 2 in 100 people with simple fatty liver might progress to cirrhosis over 15-20 years, approximately 12 in 100 people with NASH progress to cirrhosis over about eight years. The condition may even reverse, especially with weight loss or good diabetes control.
Leitura adicional e referências
- Non-alcoholic fatty liver disease (NAFLD); NICE CKS, outubro de 2023 (acesso apenas no Reino Unido)
- EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
- EASL Policy Statement on Food, obesity and Non-Alcoholic Fatty Liver Disease (NAFLD); European Association for the Study of the Liver, 2019
Sobre o autorVer biografia completa

Dr Doug McKechnie, MRCGP
Redator Médico
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
O Dr. Doug McKechnie é um médico do NHS que trabalha em Londres. Ele trabalha em tempo integral na prática clínica e também é o Vice-Líder do módulo de Prática Clínica e Profissional na Faculdade de Medicina da University College London.
Sobre o revisorVer biografia completa

Dr Colin Tidy, MRCGP
Médico Generalista, Autor Médico
MBBS, MRCGP, MRCP (Paediatrics), DCH
Dr Colin Tidy é um médico do NHS, baseado em Oxfordshire.
Histórico do artigo
As informações nesta página são escritas e revisadas por clínicos qualificados.
Artigo também disponível em Inglês, Alemão, Espanhol, Francês, Italiano, Português, Hindi, Hebraico, Árabe, e Sueco.
Próxima revisão prevista para: 6 Jan 2028
22 Fev 2023 | Última versão

Pergunte, compartilhe, conecte-se.
Navegue por discussões, faça perguntas e compartilhe experiências em centenas de tópicos de saúde.

Sentindo-se mal?
Avalie seus sintomas online gratuitamente
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.
Mais sobre saúde digestiva
- Massas abdominais
- Pancreatite aguda
- Aminossalicilatos
- Fístula anal
- Câncer de intestino
- Rastreamento de câncer de intestino
- Úlcera duodenal
- Teste imunológico fecal
- Cálculos biliares
- Giardia
- Testes de função hepática
- Laceração de Mallory-Weiss
- Adenite mesentérica
- Câncer de pâncreas
- Colangite biliar primária
- Proctalgia fugaz e dor anal
- Sangramento retal
- Dor no quadrante superior direito
- Rotavírus
- Cuidados dietéticos com estoma